Loading insider details...
Latest Form 4 (Jun 22, 2026): Grant/Award of 5,248 HROW shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | HARROW, INC. (HROW) | Grant/Award | 5,248 | n/a |
| Jun 12, 2026 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/Award | 14,000 | n/a |
| May 19, 2026 | HARROW, INC. (HROW) | Purchase | 1,000 | $31.1K |
| Apr 22, 2026 | Opus Genetics, Inc. (IRD) | Grant/Award | 24,367 | n/a |
| Jan 5, 2026 | Opus Genetics, Inc. (IRD) | Grant/Award | 23,643 | n/a |
| Jun 24, 2025 | HARROW, INC. (HROW) | Grant/Award | 7,339 | n/a |
| Jun 13, 2025 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/Award | 14,000 | n/a |
| May 2, 2025 | Opus Genetics, Inc. (IRD) | Grant/Award | 79,504 | n/a |
| Oct 24, 2024 | Opus Genetics, Inc. (IRD) | Grant/Award | 172,874 | n/a |
| Jul 26, 2024 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/Award | 12,000 | n/a |